(University of Southern California) The human brain holds many clues about a person’s long-term health. In fact, research shows that a person’s brain age is a more useful and accurate predictor of health risks and future disease than birthdate. Now, a new artificial intelligence (AI) model that analyzes magnetic resonance imaging (MRI) brain scans developed by USC researchers could be used to accurately capture cognitive decline linked to neurodegenerative diseases such as Alzheimer’s much earlier than previous methods.
Brain aging is considered a reliable biomarker for neurodegenerative disease risk. Such risk increases when a person’s brain exhibits features that appear “older” than expected for someone of that person’s age. By tapping into the deep-learning capability of the team’s novel AI model to analyze the scans, the researchers can detect subtle brain anatomy markers that are otherwise very difficult to detect and that correlate with cognitive decline. Their findings, published in the journal Proceedings of the National Academy of Sciences, offer an unprecedented glimpse into human cognition.
“Our study harnesses the power of deep learning to identify areas of the brain that are aging in ways that reflect a cognitive decline that may lead to Alzheimer’s,” said Andrei Irimia, assistant professor of gerontology, biomedical engineering, quantitative and computational biology and neuroscience at the USC Leonard Davis School of Gerontology and corresponding author of the study.
“People age at different rates, and so do tissue types in the body. We know this colloquially when we say, ‘So-and-so is 40, but looks 30. The same idea applies to the brain. The brain of a 40-year-old may look as ‘young’ as the brain of a 30-year-old, or it may look as ‘old’ as that of a 60-year-old.”
Irimia and his team collated the brain MRIs of 4,681 cognitively normal participants, some of whom went on to develop cognitive decline or Alzheimer’s disease later in life.
Using these data, they created an AI model called a neural network to predict participants’ ages from their brain MRIs. First, the researchers trained the network to produce detailed anatomic brain maps that reveal subject-specific patterns of aging. They then compared the perceived (biological) brain ages with the actual (chronological) ages of study participants. The greater the difference between the two, the worse the participants’ cognitive scores, which reflect Alzheimer’s risk.
The results show that the team’s model can predict the true (chronological) ages of cognitively normal participants with an average absolute error of 2.3 years, which is about one year more accurate than an existing, award-winning model for brain age estimation that used a different neural network architecture.
“Interpretable AI can become a powerful tool for assessing the risk for Alzheimer’s and other neurocognitive diseases,” said Irimia. “The earlier we can identify people at high risk for Alzheimer’s disease, the earlier clinicians can intervene with treatment options, monitoring, and disease management. What makes AI especially powerful is its ability to pick up on subtle and complex features of aging that other methods cannot and that are key in identifying a person’s risk many years before they develop the condition.”
The new model also reveals sex-specific differences in how aging varies across brain regions. Certain parts of the brain age faster in males than in females, and vice versa.
Males, who are at higher risk of motor impairment due to Parkinson’s disease, experience faster aging in the brain’s motor cortex, an area responsible for motor function. Findings also show that, among females, typical aging may be relatively slower in the right hemisphere of the brain.
Applications of this work extend far beyond disease risk assessment. Irimia envisions a world in which the novel deep-learning methods developed as part of the study are used to help people understand how fast they are aging in general.